Physician profile
Meredith Clair Stevens
NPI 1265258198
$2,784.05
in general payments reported to CMS, 2019-2025
15 companies · $2,784 in 2025
The $2,784 reported for 2025 was more than what 99% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $2,784.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,664 · Travel and Lodging: $1,120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,663.70 |
| Travel and Lodging | $1,120.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $1,528.19 | 2025 | Vns Therapy |
| Neurelis, INC. | $367.46 | 2025 | Valtoco |
| Ucb, INC. | $234.05 | 2025 | Fintepla, Nayzilam |
| Sk Life Science, INC. | $192.57 | 2025 | Xcopri |
| Jazz Pharmaceuticals INC. | $101.39 | 2025 | |
| Argenx US, INC. | $66.83 | 2025 | Vyvgart Hytrulo |
| Alexion Pharmaceuticals, INC. | $58.07 | 2025 | Koselugo |
| Azurity Pharmaceuticals, INC. | $45.20 | 2025 | Zonisade |
| Csl Behring | $43.75 | 2025 | Hizentra |
| Catalyst Pharmaceuticals, INC. | $42.13 | 2025 | |
| Aquestive Therapeutics, INC. | $26.37 | 2025 | |
| Pfizer INC. | $23.25 | 2025 | |
| Collegium Pharmaceutical, INC. | $18.81 | 2025 | Jornay Pm |
| Tris Pharma INC | $18.00 | 2025 | Dyanavel Xr |
| Springworks Therapeutics, INC. | $17.98 | 2025 | Gomekli |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Stevens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.